BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Katsoulidou A, Moschidis Z, Sypsa V, Chini M, Papatheodoridis GV, Tassopoulos NC, Mimidis K, Karafoulidou A, Hatzakis A. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load. Vox Sang 2007;92:8-14. [DOI: 10.1111/j.1423-0410.2006.00857.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang MH, Li L, Hung YS, Hung CS, Allain JP, Lin KS, Tsai SJ. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan. Transfusion. 2010;50:65-74. [PMID: 19709394 DOI: 10.1111/j.1537-2995.2009.02357.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
2 Safic Stanic H, Babic I, Maslovic M, Dogic V, Bingulac-Popovic J, Miletic M, Jurakovic-Loncar N, Vuk T, Strauss-Patko M, Jukic I. Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia. Transfus Med Hemother 2017;44:415-20. [PMID: 29344018 DOI: 10.1159/000457965] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
3 Said ZNA. An overview of occult hepatitis B virus infection. World J Gastroenterol 2011; 17(15): 1927-1938 [PMID: 21528070 DOI: 10.3748/wjg.v17.i15.1927] [Cited by in CrossRef: 98] [Cited by in F6Publishing: 84] [Article Influence: 9.8] [Reference Citation Analysis]
4 Candotti D, Allain JP. Transfusion-transmitted hepatitis B virus infection. J Hepatol. 2009;51:798-809. [PMID: 19615780 DOI: 10.1016/j.jhep.2009.05.020] [Cited by in Crossref: 115] [Cited by in F6Publishing: 122] [Article Influence: 9.6] [Reference Citation Analysis]
5 Niederhauser C. Reducing the risk of hepatitis B virus transfusion-transmitted infection. J Blood Med 2011;2:91-102. [PMID: 22287868 DOI: 10.2147/JBM.S12899] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
6 Kleinman S. Blood donor screening with nucleic acid amplification tests for human immunodeficiency virus, hepatitis C virus and hepatitis B virus. ISBT Science Series 2008;3:191-5. [DOI: 10.1111/j.1751-2824.2008.00167.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
7 Paraskevis D, Beloukas A, Haida C, Katsoulidou A, Moschidis Z, Hatzitheodorou H, Varaklioti A, Sypsa V, Hatzakis A. Development of a new ultra sensitive real-time PCR assay (ultra sensitive RTQ-PCR) for the quantification of HBV-DNA. Virol J. 2010;7:57. [PMID: 20226057 DOI: 10.1186/1743-422x-7-57] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
8 Sgourou A, Karakantza M, Theodori E, Papadimitriou C, Theodorou GL, Davanos N, Thymianou S, Zoumbos NC, Mouzaki A. Procleix Ultrio transcription-mediated amplification vs. serological blood screening in south-western Greece. Transfus Med 2008;18:104-11. [DOI: 10.1111/j.1365-3148.2008.00847.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Tang JW, Ng Y, Koay ESC, Leow GH, Yap ES, Chan D, Tan LK, Tambyah PA. A Febrile Blood Donor. Clinical Chemistry 2010;56:352-6. [DOI: 10.1373/clinchem.2009.131623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Jia J, Hong M, Wei L, Zhang X, Mao Y, Wang L, Gao Z, Hou J, Zhang J. Multicentre evaluation of the Elecsys® hepatitis B surface antigen II assay for detection of HBsAg in comparison with other commercially available assays. Med Microbiol Immunol 2009;198:263-9. [DOI: 10.1007/s00430-009-0127-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
11 Nick S, Scheiblauer H. Sensitivities of CE-marked HIV, HCV, and HBsAg assays. J Med Virol 2007;79:S59-64. [DOI: 10.1002/jmv.20965] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
12 Allison KM, Faddy HM, Margaritis A, Ismay S, Marks DC. The impact on blood donor screening for human immunodeficiency virus, hepatitis C virus, and hepatitis B virus using plasma from frozen-thawed plasma preparation tubes. Transfusion 2016;56:449-56. [PMID: 26456378 DOI: 10.1111/trf.13372] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Weusten JJ. A statistical approach to assess analytical sensitivity of diagnostic assays in the presence of false-positive results. J Virol Methods 2008;151:308-10. [PMID: 18584887 DOI: 10.1016/j.jviromet.2008.05.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Michalak TI, Pham TN, Mulrooney-cousins PM. Molecular diagnosis of occult HCV and HBV infections. Future Virology 2007;2:451-65. [DOI: 10.2217/17460794.2.5.451] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
15 Katsoulidou A, Paraskevis D, Magiorkinis E, Moschidis Z, Haida C, Hatzitheodorou E, Varaklioti A, Karafoulidou A, Hatzitaki M, Kavallierou L. Molecular characterization of occult hepatitis B cases in Greek blood donors. J Med Virol. 2009;81:815-825. [PMID: 19319945 DOI: 10.1002/jmv.21499] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
16 Granade TC, Kodani M, Wells SK, Youngpairoj AS, Masciotra S, Curtis KA, Kamili S, Owen SM. Characterization of real-time microarrays for simultaneous detection of HIV-1, HIV-2, and hepatitis viruses. J Virol Methods 2018;259:60-5. [PMID: 29874550 DOI: 10.1016/j.jviromet.2018.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]